• Oct 06, 2013 | Webcast

    Sclerostin: The Journey from Discovery to Application

    Bejamin Leder, MD; Michaela Kneissel, PhD; Socrates Papapoulos, MD; Matthew Drake, MD, PhD; John Bilezikian, MD
    Molecular Cellular and Genetic Determinants of Bone Structure and Formation

    Benjamin Leder, M.D.
    Massachusetts General Hospital, Harvard Medical School, USA

    Michaela Kneissel, Ph.D.
    Novartis Institutes for Biomedical Research, Switzerland

    Lessons from Human Genetic Diseases (Not included in webcast)
    Socrates Papapoulos, M.D.
    Leiden University Medical Center, The Netherlands

    Circulating Sclerostin as a Marker of Bone Health and Disease
    Matthew Drake, M.D., Ph.D.
    College of Medicine, Mayo Clinic, USA

    Sclerostin Antagonism: Clinical Applications and Therapeutic Potential
    John Bilezikian, M.D.
    Columbia University College of Physicians and Surgeons, USA

    Supported by educational grants from Lilly USA, LLC and Merck & Co., Inc.

    Length: 60 minutes

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details